Of interest are recent reports that metformin (a drug used to treat type 2 diabetes but that is intensively studied for its potential anti-cancer effects) can interfere with both the secretion of and the response to TGF-β1 as well as the TGF-β1 itself [84–86]. The gene discussed is TGFB1; the disease is cancer.